The epidemiology of invasive pneumococcal disease in older adults from 2007 to 2014 in Ontario, Canada: a population-based study
Background: In Ontario, pneumococcal conjugate vaccines (PCVs) have been sequentially
introduced into the publicly funded childhood vaccination program since 2005. A 23-valent …
introduced into the publicly funded childhood vaccination program since 2005. A 23-valent …
[HTML][HTML] Forecasting trends in invasive pneumococcal disease among elderly adults in Quebec
Z Zhou, G Deceuninck, B Lefebvre… - Canadian Journal of …, 2017 - hindawi.com
Background. In Canada, the current recommendation is to offer PPV23 to adults≥ 65 years.
PCV13 is now licensed for adults. Methods. Invasive pneumococcal disease (IPD) cases in …
PCV13 is now licensed for adults. Methods. Invasive pneumococcal disease (IPD) cases in …
Trends in invasive pneumococcal disease among older adults in Olmsted County, Minnesota
C Tsigrelis, IM Tleyjeh, BD Lahr, LM Nyre, A Virk… - Journal of Infection, 2009 - Elsevier
OBJECTIVE: Following the introduction of a 7-valent pneumococcal conjugate vaccine (PCV-
7) for children in early 2000 in the United States, a decrease in the incidence of invasive …
7) for children in early 2000 in the United States, a decrease in the incidence of invasive …
The epidemiology of invasive pneumococcal disease in older adults in the post-PCV era. Has there been a herd effect?
M Corcoran, I Vickers, J Mereckiene… - Epidemiology & …, 2017 - cambridge.org
The 7 and 13-valent pneumococcal conjugate vaccines (PCVs) have reduced the incidence
of invasive pneumococcal disease (IPD) in children in many countries. The objective of this …
of invasive pneumococcal disease (IPD) in children in many countries. The objective of this …
[HTML][HTML] Epidemiology of invasive pneumococcal disease in older people in Spain (2007–2009): implications for future vaccination strategies
C Ardanuy, JM Marimón, L Calatayud, M Gimenez… - 2012 - journals.plos.org
Background Recently, the 13-valent pneumococcal conjugate vaccine (PCV13) has been
recommended for adults. We analyzed the epidemiology of invasive pneumococcal disease …
recommended for adults. We analyzed the epidemiology of invasive pneumococcal disease …
Declining invasive pneumococcal disease in the US elderly
AM McBean, YT Park, D Caldwell, X Yu - Vaccine, 2005 - Elsevier
In 2000, pneumococcal conjugate vaccine (PCV7) was recommended for young children. By
2002–2003, 48.6% had been fully immunized. Using Medicare administrative, we found that …
2002–2003, 48.6% had been fully immunized. Using Medicare administrative, we found that …
Changing epidemiology of invasive pneumococcal disease among older adults in the era of pediatric pneumococcal conjugate vaccine
CA Lexau, R Lynfield, R Danila, T Pilishvili, R Facklam… - Jama, 2005 - jamanetwork.com
ContextA conjugate vaccine targeting 7 pneumococcal serotypes was licensed for young
children in 2000. In contrast to the 23-valent polysaccharide vaccine used in adults, the 7 …
children in 2000. In contrast to the 23-valent polysaccharide vaccine used in adults, the 7 …
Decreasing invasive pneumococcal disease in the elderly: a state-level analysis
AM McBean, K Jung, PL Hebert - Vaccine, 2006 - Elsevier
Evidence has accumulated supporting the relationship between the use of 7-valent
pneumococcal conjugate vaccine (PCV7) in children and a decline in invasive …
pneumococcal conjugate vaccine (PCV7) in children and a decline in invasive …
[HTML][HTML] Distribution of serotypes causing invasive pneumococcal disease in older adults from high-income countries and impact of pediatric and adult vaccination …
LR Grant, MPE Slack, C Theilacker, J Vojicic, S Dion… - Vaccine, 2023 - Elsevier
Background Neither indirect protection through use of 13-valent and 10-valent
pneumococcal conjugate vaccines (PCV13 and PCV10) in pediatric National Immunization …
pneumococcal conjugate vaccines (PCV13 and PCV10) in pediatric National Immunization …
[HTML][HTML] The shifting epidemiology and serotype distribution of invasive pneumococcal disease in Ontario, Canada, 2007-2017
S Wijayasri, K Hillier, GH Lim, TM Harris, SE Wilson… - PLoS …, 2019 - journals.plos.org
Background Ontario, Canada introduced a publicly-funded 13-valent pneumococcal
conjugate vaccine (PCV13) for infants in 2010, replacing the 10-valent (PCV10, 2009–2010) …
conjugate vaccine (PCV13) for infants in 2010, replacing the 10-valent (PCV10, 2009–2010) …
